Zurich Cantonal Bank
KRTX

Zurich Cantonal Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Zurich Cantonal Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,770
Closed -$1.83M – 2747
2023
Q4 		$1.83M Buy
5,770
+550
+11% +$107K 0.01% 768
2023
Q3 		$883K Buy
5,220
+1,067
+26% +$201K ﹤0.01% 1037
2023
Q2 		$901K Buy
4,153
+581
+16% +$124K ﹤0.01% 981
2023
Q1 		$649K Buy
3,572
+281
+9% +$53.7K ﹤0.01% 1149
2022
Q4 		$647K Sell
3,291
-333
-9% -$71.4K ﹤0.01% 1107
2022
Q3 		$815K Buy
3,624
+2,664
+278% +$539K ﹤0.01% 918
2022
Q2 		$121K Sell
960
-17
-2% -$1.95K ﹤0.01% 2113
2022
Q1 		$124K Buy
977
+237
+32% +$26.7K ﹤0.01% 2177
2021
Q4 		$97K Buy
740
+429
+138% +$55.4K ﹤0.01% 2526
2021
Q3 		$38K Hold
311
– – ﹤0.01% 2697
2021
Q2 		$35K Hold
311
– – ﹤0.01% 2521
2021
Q1 		$37K Hold
311
– – ﹤0.01% 2467
2020
Q4 		$32K Hold
311
– – ﹤0.01% 2533
2020
Q3 		$24K Buy
+311
New +$26.5K ﹤0.01% 2459

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Zurich Cantonal Bank's KRTX Position: Q1 2024 in Review

Zurich Cantonal Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5,770 shares — an estimated $1.83M sold.

Zurich Cantonal Bank first reported a position in KRTX in Q3 2020 and held it in 14 quarters. The position peaked at $1.83M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Zurich Cantonal Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 5,770 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.83M.
  • Zurich Cantonal Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Zurich Cantonal Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $1.83M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Zurich Cantonal Bank's 13F filing for Q1 2024, filed 25 Apr 2024.